As part of new agreements announced at the 7th edition of the Global Health Forum, Saudi Arabia signed deals to localize the ...

Diabetes is a global health concern, making it essential to ensure a continuous and reliable supply of high-quality insulin ...

Sanofi SA (SNY) reports a robust 16% sales increase, driven by Dupixent and vaccines, while navigating market challenges and ...

A new ad playing on TV, endorsed by Kaine, says he worked to lower insulin prices. We verify that claim before Election Day.

Q3 2024 Earnings Call Transcript October 25, 2024 Sanofi beats earnings expectations. Reported EPS is $1.57, expectations ...

The Global Health Exhibition 2024 witnessed today, Oct. 22, the signing of a final agreement to localize the production of ...

Wyoming’s attorney general, through a settlement with a French multinational pharmaceutical and healthcare company, has ...

The settlement announced by Attorney General Bridget Hill on Friday morning with Sanofi-Aventis U.S. will be put into effect within 90 days of Sept. 27. The cost of insulin has soared over the ...

CHEYENNE – Attorney General Bridget Hill announced a settlement with Sanofi-Aventis U.S. LLC (Sanofi ... health care programs can buy Sanofi’s insulin products for $35 per month for the ...

12 February 2018, Sanofi India announced the launch of its new insulin product Toujeo. Toujeo is a once-daily, long-acting basal analog insulin that improves glycemic control in adults with type 1 ...

Head of Investor Relations Welcome to the Q3 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide number 3. Here we have the usual ...